PATRICIA CARMEN
MUÑOZ GARCÍA
Catedrática de universidad
FERNANDO
GONZÁLEZ ROMO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con FERNANDO GONZÁLEZ ROMO (17)
2024
-
Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution
Mycoses, Vol. 67, Núm. 3
-
Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme
Clinical Microbiology and Infection
2023
-
Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates
Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6
-
Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228
Journal of Fungi
-
Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid
Revista Espanola de Quimioterapia
-
Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022
Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 11
2022
-
Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3102-3109
-
Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis
Journal of Fungi, Vol. 8, Núm. 11
-
Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8
2021
-
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection
Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761
2019
-
Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome
Transplant Infectious Disease, Vol. 21, Núm. 6
2018
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19
2017
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9